Bowen Hanes & Co’s Teladoc Health TDOC Stock Holding History

Bowen Hanes & Co’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-100,000	Closed	-$20M	–	152
2020 Q4	$20M	Hold	100,000	–	–	0.66%	59
2020 Q3	$21.9M	Hold	100,000	–	–	0.79%	54
2020 Q2	$19.1M	Buy	100,000 +5,000	+5%	+$876K	0.77%	50
2020 Q1	$14.7M	Buy	+95,000	New	+$11.1M	0.72%	49

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

DVF

Discovery Value Fund Singapore $34.7M AUM 58.56% 1-Year Est. Return

Bowen Hanes & Co's TDOC Position: Q1 2021 in Review

Bowen Hanes & Co sold out of Teladoc Health (TDOC) in Q1 2021, closing a stake of 100,000 shares — an estimated $20M sold.

Bowen Hanes & Co first reported a position in TDOC in Q1 2020 and held it in 4 quarters. The position peaked at $21.9M in Q3 2020. 889 funds tracked by Wall St. Rank hold TDOC as of Q1 2021.

Bowen Hanes & Co reported no remaining Teladoc Health position as of Q1 2021 after selling out during the quarter.
Bowen Hanes & Co sold 100,000 Teladoc Health shares in Q1 2021, an estimated $20M.
Bowen Hanes & Co first reported a position in Teladoc Health in Q1 2020 and held it in 4 quarters.
Bowen Hanes & Co's Teladoc Health position peaked at $21.9M in Q3 2020.
889 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2021.

Based on Bowen Hanes & Co's 13F filing for Q1 2021, filed 13 May 2021.